Fernando M. Rodrigues - 29 Nov 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
29 Nov 2024
Net transactions value
-$249,903
Form type
4
Filing time
03 Dec 2024, 17:26:53 UTC
Previous filing
27 Sep 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +21,964 21,964 29 Nov 2024 Direct F1
transaction TDOC Common Stock Sale $93,901 -7,873 -36% $11.93 14,091 02 Dec 2024 Direct F2
transaction TDOC Common Stock Sale $156,001 -14,091 -100% $11.07 0 03 Dec 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -21,964 -33% $0.000000 43,930 29 Nov 2024 Common Stock 21,964 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 Represents the weighted average price of transactions ranging from $11.07 to $11.085, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4 On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.